Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis

被引:34
|
作者
Pedersen, Julie Steen [1 ]
Rygg, Marte Opseth [1 ]
Kristiansen, Viggo Bjerregaard [2 ]
Olsen, Beth Hrstedt [3 ]
Serizawa, Reza Rafiolsadat [4 ]
Holst, Jens Juul [5 ]
Madsbad, Sten [6 ]
Gluud, Lise Lotte [1 ]
Bendtsen, Flemming [1 ]
Albrechtsen, Nicolai Jacob Wewer [5 ,7 ,8 ]
机构
[1] Copenhagen Univ Hosp Hvidovre, Gastrounit, Med Div, Kettegaard 30, DK-2650 Hvidovre, Denmark
[2] Copenhagen Univ Hosp Hvidovre, Gastrounit, Surg Div, Hvidovre, Denmark
[3] Copenhagen Univ Hosp Hvidovre, Dept Nucl Med & Funct Imaging, Ultrasound Sect, Hvidovre, Denmark
[4] Copenhagen Univ Hosp Hvidovre, Dept Pathol, Hvidovre, Denmark
[5] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark
[6] Copenhagen Univ Hosp Hvidovre, Dept Endocrinol, Hvidovre, Denmark
[7] Univ Copenhagen, Dept Clin Biochem, Rigshosp, Blegdamsvej 3, DK-2200 Copenhagen, Denmark
[8] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark
关键词
INSULIN-RESISTANCE; GLUCAGON; GLUCOSE; SUPPRESSION; GLUTAMINE; OBESITY; IMPACT; MASS;
D O I
10.1002/hep4.1562
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is associated with impaired hepatic actions of glucagon and insulin. Glucagon and amino acids are linked in an endocrine feedback circuit, the liver-alpha cell axis, that may be disrupted by NAFLD. We investigated how NAFLD severity affects glucagon and insulin resistance in individuals with obesity and whether bariatric surgery improves these parameters. Plasma and liver biopsies from 33 individuals with obesity (collectively, OBE) were obtained before and 12 months after bariatric surgery (Roux-en-Y gastric bypass [RYGB] or sleeve gastrectomy [SG]). Nine healthy control individuals (collectively, CON) undergoing cholecystectomy were used as a comparison group. The NAFLD activity score (NAS) was used to subdivide study participants into the following groups: OBE-no steatosis, OBE+steatosis, and nonalcoholic steatohepatitis (NASH) and/or grade 2 fibrosis (Fib) (OBE-NASH-Fib). Measurements of amino acids by targeted metabolomics and glucagon were performed. Glucagon, amino acids (P < 0.05), and the glucagon-alanine index, a validated surrogate marker of glucagon resistance, were increased in OBE by 60%, 56%, and 61%, respectively, when compared with CON but irrespective of NAFLD severity. In contrast, markers of hepatic insulin resistance increased concomitantly with NAS. Hyperglucagonemia resolved in OBE-no steatosis and OBE+steatosis but not in OBE-NASH-Fib (median, 7.0; interquartile range, 5.0-9.8 pmol/L), regardless of improvement in insulin resistance and NAS. The type of surgery that participants underwent had no effect on metabolic outcomes.Conclusion:Glucagon resistance to amino acid metabolism exists in individuals with NAFLD independent of NAS severity. Patients with NASH showed persistent hyperglucagonemia 12 months after bariatric surgery, indicating that a disrupted liver-alpha cell may remain in NAFLD despite major improvement in liver histology.
引用
收藏
页码:1610 / 1623
页数:14
相关论文
共 50 条
  • [1] Association of metabolic syndrome with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease
    Moon, Joon Ho
    Park, Sang Hoon
    Yoo, Byoung Kwan
    Park, Kwang Hyuk
    Chung, Yong Woo
    Kim, Kyoung Oh
    Park, Cheol Hee
    Hahn, Taeho
    Yoo, Kyo-Sang
    Kim, Jong Hyeok
    Park, Choong Kee
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S172 - S172
  • [2] Leptin is an independent marker of liver fibrosis in humans with nonalcoholic fatty liver disease
    Alba, LM
    Petrovic, L
    Lindor, KD
    Talwalkar, JA
    Angulo, P
    HEPATOLOGY, 2002, 36 (04) : 296A - 296A
  • [3] Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
    Hossain, Noreen
    Afendy, Arian
    Stepanova, Maria
    Nader, Fatema
    Srishord, Manirath
    Rafiq, Nila
    Goodman, Zachary
    Younossi, Zobair
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (11) : 1224 - 1229
  • [4] Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease
    Zein, Claudia O.
    Unalp, Aynur
    Colvin, Ryan
    Liu, Yao-Chang
    McCullough, Arthur J.
    JOURNAL OF HEPATOLOGY, 2011, 54 (04) : 753 - 759
  • [5] Independent regulation of tumorigenesis and fibrosis in nonalcoholic fatty liver disease
    Gillman, Rhys
    Hebbard, Lionel
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (01) : 106 - 108
  • [6] Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease
    Saumya Jayakumar
    Stephen A. Harrison
    Rohit Loomba
    Current Hepatology Reports, 2016, 15 (2) : 86 - 95
  • [7] GLYCEMIC VARIABILITY IS AN INDEPENDENT PROGNOSTIC FACTOR FOR DEVELOPMENT OF HEPATIC FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE
    Ono, M.
    Hashiba, M.
    Hyogo, H.
    Ikeda, Y.
    Masuda, K.
    Yoshioka, R.
    Munekage, K.
    Ochi, T.
    Ogasawara, M.
    Hirose, A.
    Takahashi, M.
    Noguchi, S.
    Okamoto, N.
    Iwasaki, S.
    Chayama, K.
    Suganuma, N.
    Saibara, T.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S545 - S545
  • [8] Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease
    Ochi, Tsunehiro
    Hashiba, Motoi
    Ono, Masafumi
    Hyogo, Hideyuki
    Ikeda, Yukio
    Munekage, Kensuke
    Okamoto, Nobuto
    Iwasaki, Shinji
    Chayama, Kazuaki
    Eguchi, Yuichiro
    Saibara, Toshiji
    HEPATOLOGY, 2013, 58 : 505A - 505A
  • [9] OBSTRUCTIVE SLEEP APNEA WORSENS HEPATIC INFLAMMATION AND FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Piercy, Dawn L.
    Suzuki, Ayako
    Feng, Jing
    Pan, Yiping
    Guy, Cynthia D.
    Diehl, Anna Mae
    Chiang, Ambrose A.
    Abdelmalek, Manal F.
    HEPATOLOGY, 2010, 52 (04) : 631A - 631A
  • [10] Glycemic Variability Is an Independent Predictive Factor for Development of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
    Hashiba, Motoi
    Ono, Masafumi
    Hyogo, Hideyuki
    Ikeda, Yukio
    Masuda, Kosei
    Yoshioka, Reiko
    Ishikawa, Yoichi
    Nagata, Yuri
    Munekage, Kensuke
    Ochi, Tsunehiro
    Hirose, Akira
    Nozaki-Fujimura, Yasuko
    Noguchi, Shuhei
    Okamoto, Nobuto
    Chayama, Kazuaki
    Suganuma, Narufumi
    Saibara, Toshiji
    PLOS ONE, 2013, 8 (11):